1. Home
  2. MHO vs LGND Comparison

MHO vs LGND Comparison

Compare MHO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MHO

M/I Homes Inc.

HOLD

Current Price

$146.52

Market Cap

3.4B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$294.76

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHO
LGND
Founded
1976
1987
Country
United States
United States
Employees
N/A
68
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MHO
LGND
Price
$146.52
$294.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$160.00
$256.29
AVG Volume (30 Days)
273.1K
489.9K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.55
N/A
Revenue
$4,417,781,000.00
N/A
Revenue This Year
$0.66
$1.25
Revenue Next Year
$6.97
$19.41
P/E Ratio
$58.44
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$116.78
$131.67
52 Week High
$163.66
$326.63

Technical Indicators

Market Signals
Indicator
MHO
LGND
Relative Strength Index (RSI) 47.83 53.27
Support Level $126.16 $180.85
Resistance Level $152.14 $326.63
Average True Range (ATR) 4.06 11.32
MACD -1.26 -4.58
Stochastic Oscillator 12.91 14.88

Price Performance

Historical Comparison
MHO
LGND

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: